The NASDAQ 100 After Hours Indicator is down -.85 to 3,742.74. The total After hours volume is currently 17,475,187 shares traded.
The following are the most active stocks for the after hours session :
Weyerhaeuser Company ( WY ) is unchanged at $30.98, with 4,605,689 shares traded. WY's current last sale is 91.12% of the target price of $34.
Ally Financial Inc. ( ALLY ) is unchanged at $23.51, with 2,230,092 shares traded. ALLY's current last sale is 83.96% of the target price of $28.
Whole Foods Market, Inc. ( WFM ) is +0.03 at $38.41, with 2,027,454 shares traded. WFM's current last sale is 82.6% of the target price of $46.5.
Forest Laboratories, Inc. ( FRX ) is unchanged at $94.77, with 1,498,774 shares traded. FRX's current last sale is 102.45% of the target price of $92.5.
Exxon Mobil Corporation ( XOM ) is unchanged at $100.04, with 756,121 shares traded. XOM's current last sale is 93.5% of the target price of $107.
Regions Financial Corporation ( RF ) is unchanged at $10.49, with 573,436 shares traded. RF's current last sale is 89.93% of the target price of $11.665.
Protective Life Corporation ( PL ) is unchanged at $69.36, with 555,518 shares traded. Over the last four weeks they have had 4 up revisions for the earnings forecast, for the fiscal quarter ending Sep 2014. The consensus EPS forecast is $1.22. , following a 52-week high recorded in today's regular session.
Intel Corporation ( INTC ) is +0.05 at $27.65, with 529,735 shares traded. As reported in the last short interest update the days to cover for INTC is 7.933455; this calculation is based on the average trading volume of the stock.
Comcast Corporation ( CMCSA ) is unchanged at $52.29, with 460,940 shares traded. As reported by Zacks, the current mean recommendation for CMCSA is in the "buy range".
Microsoft Corporation ( MSFT ) is unchanged at $40.32, with 426,091 shares traded. MSFT's current last sale is 94.87% of the target price of $42.5.
PowerShares QQQ Trust, Series 1 ( QQQ ) is -0.01 at $91.51, with 421,681 shares traded., following a 52-week high recorded in today's regular session.
Halozyme Therapeutics, Inc. ( HALO ) is +1.02 at $9.10, with 398,662 shares traded. HALO's current last sale is 75.83% of the target price of $12.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.